RxDoctor Payments Data

Amber Keller, PA

Physician Assistant · Winston Salem, NCNPI 1164779997

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $46,838 of the $65,087 with a category attached, or 72.0%. Johnson & Johnson accounts for 92.6% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $36,300, more than ten times the $733 reported in 2021. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$65,087in general payments, 2019–2025

Across 492 payments — averaging $132.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$60K
  • AbbVie$2K
  • Regeneron Healthcare Solutions, Inc.$509
  • Sanofi$322
  • Amgen$275
  • UCB, Inc.$266
  • plus $2K from 13 others

What the payments were for

  • Consulting fees$1,0632%
  • Speaking & faculty fees$46,83872%
  • Travel & lodging$9,74215%
  • Food & beverage$6,93011%
  • Education$5151%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$65,087 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$68,627
Medicare patients
319
Services billed
1,289

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TremfyaGuselkumab18$246,466
Dupixent PenDupilumab57$213,710
SiliqBrodalumab14$71,907
Fluorouracil22$2,082
Betamethasone Dipropionate58$1,868
Ketoconazole71$1,008
Triamcinolone Acetonide172$890
Clobetasol Propionate25$769
Gabapentin49$752
Imiquimod17$664
ValacyclovirValacyclovir Hcl13$519
Clindamycin Phosphate15$504
Metronidazole13$499
Minocycline Hcl24$439
Hydroxyzine Hcl16$262

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonTremfya$60,300$246,46618 claims
Ortho Dermatologics, A Division Of Bausch Health US, LLCSiliq$122$71,90714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →